# NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2018

- Company: [NEUROONE MEDICAL TECHNOLOGIES Corp](/companies/nmtc.md) (CIK 1500198)
- Form: 10-Q
- Filed: 2018-08-13
- Accepted by EDGAR: Aug 13, 2018, 20:05 ET
- Period: 2018-06-30
- Accession: 0001213900-18-010817
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1500198/000121390018010817/f10q0618_neuroonemedical.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1500198/000121390018010817/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2018-04-01 to 2018-06-30 | $225.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-01-01 to 2018-06-30 | $330.6k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-04-01 to 2018-06-30 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-01-01 to 2018-06-30 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2018-04-01 to 2018-06-30 | −$1.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-01-01 to 2018-06-30 | −$2.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-04-01 to 2018-06-30 | −$0.16 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2018-01-01 to 2018-06-30 | −$0.33 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2018-01-01 to 2018-06-30 | −$1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | at 2018-06-30 | $23.2k | us-gaap:AssetsCurrent |
| Total assets | at 2018-06-30 | $229.7k | us-gaap:Assets |
| Current liabilities | at 2018-06-30 | $3.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-06-30 | $7.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-06-30 | −$7.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1500198/000121390018010817/f10q0618_neuroonemedical.htm

Filed Aug 13, 2018.
Source: SEC EDGAR, the filing index for accession 0001213900-18-010817. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
